
NATURE . COM {
}
Title:
Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment | Nature Communications
Description:
Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanine–alanine–asparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,058 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,617.
Keywords {🔍}
legumain, cells, nanoparticles, tumour, cancer, article, doxorubicin, pubmed, aantatlipo, google, scholar, cas, fig, drug, breast, analysis, cell, tat, shown, results, expression, loaded, data, delivery, mouse, mice, substrate, macrophages, lysates, nature, targeting, aan, tissue, incubated, treatment, peptide, activity, liposomal, supplementary, china, usa, active, aantatlipodox, site, control, human, antibody, group, represent, model,
Topics {✒️}
nature portfolio 2-dioleoyl-sn-glycero-3-phospho-ethanolamine-n-[methoxy permissions reprints carbobenzyloxy–alanine–alanine–asparagine–ethylenediamine–etoposide privacy policy plv-ef1α-legumain-ires-bsd plasmid plv-ef1α-luciferase-ires-bsd middle line represents legumain-specific substrate ala–ala–asn author information authors jandel scientific software fitc-labelled aan-tat-lipo-dox luciferase-expressing mda-mb-231 cells fitc-labelled aan-tat-lipo nanoparticles aan-tat-lipo-dox administration group aan-tat-lipo-dox treatment group advertising nature aan-tat-lipo carrying biomacromolecules aan-tat-nanoparticles sheds light aan-tat-lipo-dox group scripps research institute aan-tat-lipo nanoparticles produced aan-tat-lipo nanoparticle structure doxorubicin-loaded aan-tat-lipo nanoparticles social media oriented central-tumor delivery aan-tat-lipo-egfp group ala–ala–asn–amc41 dir-labelled aan-tat-lipo ala–ala–asn–amc mda-mb-231 mouse model 2-dioleoyl-sn-glycero-3-phosphoethanolamine 2-dioleoyl-sn-glycero-3-phosphocholine aan-tat-lipo carrier system aan-tat-lipo enhances internalization commercial substrate z-aan-amc tat-lipo-dox experimental groups aan-tat-lipo increases accumulation cleaves aan-tat-lipo luciferase-expressing a549 cells tat-lipo-dox treatment groups luciferase-expressing 4t1 cells legumain substrate z-aan-amc japan full access establishing stable legumain-expressing aan-tan-lipo nanoparticles luciferase-expressing cell lines aan-tat-lipo-dox
Schema {🗺️}
WebPage:
mainEntity:
headline:Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
description:Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanineâalanineâasparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
datePublished:2014-06-27T00:00:00Z
dateModified:2014-06-27T00:00:00Z
pageStart:1
pageEnd:11
sameAs:https://doi.org/10.1038/ncomms5280
keywords:
Drug delivery
Targeted therapies
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Figa_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig6_HTML.jpg
isPartOf:
name:Nature Communications
issn:
2041-1723
volumeNumber:5
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ze Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Min Xiong
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Junbo Gong
affiliation:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Nan Bai
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yunping Luo
affiliation:
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Luyuan Li
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yuquan Wei
affiliation:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
type:Organization
type:Person
name:Yanhua Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xiaoyue Tan
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Rong Xiang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
description:Specific targeting and cellular internalization are key properties for carriers of antitumor therapeutic agents. Here, we develop a drug carrier through the attachment of substrate of endoprotease legumain, alanineâalanineâasparagine (AAN), to cell-penetrating peptides (TAT, trans-activating factor). The addition of the AAN moiety to the fourth lysine in the TAT creates a branched peptide moiety, which leads to a decrease in the transmembrane transport capacity of TAT by 72.65%. Legumain efficiently catalyses the release of TAT-liposome from the AAN-TAT-liposome and thereby recovers the penetrating capacity of TAT. Doxorubicin carried by the AAN-TAT-liposome led to an increase in the tumoricidal effect of doxorubicin and a reduction in its systemic adverse effects in comparison with doxorubicin carried by a control delivery system. Thus, the specific targeting and high efficiency of this delivery platform offers a novel approach to limit the toxicity of anticancer agents as well as increasing their efficacy in cancer therapy. Legumain is a protease found expressed in tumour cells and may be useful in the specific targeting of chemotherapeutics to tumour cells. Here, the authors design nanoparticles that are loaded with doxorubicin and contain a legumain cleavage site; once the nanoparticles enter tumour cells legumain activity results in the release of doxorubicin.
datePublished:2014-06-27T00:00:00Z
dateModified:2014-06-27T00:00:00Z
pageStart:1
pageEnd:11
sameAs:https://doi.org/10.1038/ncomms5280
keywords:
Drug delivery
Targeted therapies
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Figa_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig5_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_Article_BFncomms5280_Fig6_HTML.jpg
isPartOf:
name:Nature Communications
issn:
2041-1723
volumeNumber:5
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Ze Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Min Xiong
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Junbo Gong
affiliation:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yan Zhang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Nan Bai
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yunping Luo
affiliation:
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
type:Organization
type:Person
name:Luyuan Li
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Yuquan Wei
affiliation:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
type:Organization
type:Person
name:Yanhua Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
type:Person
name:Xiaoyue Tan
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Rong Xiang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature Communications
issn:
2041-1723
volumeNumber:5
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Ze Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Min Xiong
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Junbo Gong
affiliation:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road
address:
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Yan Zhang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Nan Bai
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Yunping Luo
affiliation:
name:Beijing Union Medical School, 5 Dong Dan San Tiao
address:
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
type:PostalAddress
type:Organization
name:Luyuan Li
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Yuquan Wei
affiliation:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University
address:
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
type:PostalAddress
type:Organization
name:Yanhua Liu
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
name:Xiaoyue Tan
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
name:Rong Xiang
affiliation:
name:Medical School of Nankai University, 94 Weijin Road
address:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Tianjin Key Laboratory of Modern Drug Delivery and High Efficiency in Tianjin University, 92 Weijin Road, Tianjin, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Immunology, Beijing Union Medical School, 5 Dong Dan San Tiao, Beijing, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Pathology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
name:Department of Immunology, Medical School of Nankai University, 94 Weijin Road, Tianjin, China
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
Social Networks {👍}(2)
External Links {🔗}(168)
- Income figures for https://doi.org/10.1021%2Fnn4047925
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24144228 pull in monthly?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Layer-by-layer%20nanoparticles%20for%20systemic%20codelivery%20of%20an%20anticancer%20drug%20and%20sirna%20for%20potential%20triple-negative%20breast%20cancer%20treatment&journal=ACS%20Nano&doi=10.1021%2Fnn4047925&volume=7&pages=9571-9584&publication_year=2013&author=Deng%2CZJ?
- https://doi.org/10.1038%2Fnrc1893's revenue stream
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16862189's financial summary
- http://scholar.google.com/scholar_lookup?&title=Drug%20penetration%20in%20solid%20tumours&journal=Nat.%20Rev.%20Cancer&doi=10.1038%2Fnrc1893&volume=6&pages=583-592&publication_year=2006&author=Minchinton%2CAI&author=Tannock%2CIF's total income per month
- What's the financial intake of https://doi.org/10.1002%2Fanie.200301694?
- How much income does http://scholar.google.com/scholar_lookup?&title=Supramolecular%20drug-delivery%20systems%20based%20on%20polymeric%20core-shell%20architectures&journal=Angew.%20Chem.%20Int.%20Ed.&doi=10.1002%2Fanie.200301694&volume=43&pages=278-282&publication_year=2004&author=Haag%2CR have?
- How much profit does https://doi.org/10.2217%2Fnnm.13.11 generate?
- http://scholar.google.com/scholar_lookup?&title=Polymer%20nanocompartments%20in%20broad-spectrum%20medical%20applications&journal=Nanomedicine%20%28Lond%29&doi=10.2217%2Fnnm.13.11&volume=8&pages=425-447&publication_year=2013&author=Najer%2CA&author=Wu%2CD&author=Vasquez%2CD&author=Palivan%2CCG&author=Meier%2CW's revenue stream
- See how much https://doi.org/10.1016%2Fj.jconrel.2013.09.015 makes per month
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24075926
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891846 make?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Progress%20in%20microRNA%20delivery&journal=J.%20Control.%20Release&doi=10.1016%2Fj.jconrel.2013.09.015&volume=172&pages=962-974&publication_year=2013&author=Zhang%2CY&author=Wang%2CZ&author=Gemeinhart%2CRA each month?
- How much profit does https://doi.org/10.1155%2F2013%2F705265 make?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23533772
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606784?
- How much income does http://scholar.google.com/scholar_lookup?&title=Recent%20trends%20in%20multifunctional%20liposomal%20nanocarriers%20for%20enhanced%20tumor%20targeting&journal=J.%20Drug%20Deliv.&doi=10.1155%2F2013%2F705265&volume=2013&publication_year=2013&author=Perche%2CF&author=Torchilin%2CVP have?
- Earnings of https://doi.org/10.1016%2Fj.molmed.2012.04.012
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22682515
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Cell-penetrating%20peptides%3A%20breaking%20through%20to%20the%20other%20side&journal=Trends%20Mol.%20Med.&doi=10.1016%2Fj.molmed.2012.04.012&volume=18&pages=385-393&publication_year=2012&author=Koren%2CE&author=Torchilin%2CVP produce monthly?
- How much does https://doi.org/10.1016%2Fj.ijpharm.2011.09.008 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21945185 rake in every month?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Liposome%20formulated%20with%20TAT-modified%20cholesterol%20for%20improving%20brain%20delivery%20and%20therapeutic%20efficacy%20on%20brain%20glioma%20in%20animals&journal=Int.%20J.%20Pharm.&doi=10.1016%2Fj.ijpharm.2011.09.008&volume=420&pages=304-312&publication_year=2011&author=Qin%2CY
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18440319?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Cell-penetrating%20and%20cell-targeting%20peptides%20in%20drug%20delivery&journal=Biochim.%20Biophys.%20Acta.&volume=1786&pages=126-138&publication_year=2008&author=Vives%2CE&author=Schmidt%2CJ&author=Pelegrin%2CA?
- What's the revenue for https://doi.org/10.1016%2Fj.jconrel.2012.06.019?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22728515 rake in every month?
- How much does http://scholar.google.com/scholar_lookup?&title=Size-controlled%20dual-ligand%20modified%20liposomes%20that%20target%20the%20tumor%20vasculature%20show%20promise%20for%20use%20in%20drug-resistant%20cancer%20therapy&journal=J.%20Control.%20Release&doi=10.1016%2Fj.jconrel.2012.06.019&volume=162&pages=225-232&publication_year=2012&author=Takara%2CK earn?
- Monthly income for https://doi.org/10.1016%2Fj.ijpharm.2011.03.010
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21414394?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20new%20peptide%20motif%20present%20in%20the%20protective%20antigen%20of%20anthrax%20toxin%20exerts%20its%20efficiency%20on%20the%20cellular%20uptake%20of%20liposomes%20and%20applications%20for%20a%20dual-ligand%20system&journal=Int.%20J.%20Pharm.&doi=10.1016%2Fj.ijpharm.2011.03.010&volume=412&pages=106-114&publication_year=2011&author=Kibria%2CG&author=Hatakeyama%2CH&author=Harashima%2CH make?
- See how much https://doi.org/10.1016%2Fj.biomaterials.2010.10.037 makes per month
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21074847 have?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Integrin-targeted%20nanocomplexes%20for%20tumour%20specific%20delivery%20and%20therapy%20by%20systemic%20administration&journal=Biomaterials&doi=10.1016%2Fj.biomaterials.2010.10.037&volume=32&pages=1370-1376&publication_year=2011&author=Tagalakis%2CAD generate?
- Profit of https://doi.org/10.1016%2Fj.cell.2011.02.013
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21376230
- See how much http://scholar.google.com/scholar_lookup?&title=Hallmarks%20of%20cancer%3A%20the%20next%20generation&journal=Cell&doi=10.1016%2Fj.cell.2011.02.013&volume=144&pages=646-674&publication_year=2011&author=Hanahan%2CD&author=Weinberg%2CRA makes per month
- Earnings of https://doi.org/10.1615%2FCritRevOncog.v18.i1-2.70
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23237555?
- Get to know http://scholar.google.com/scholar_lookup?&title=The%20tumor%20microenvironment%3A%20a%20target%20for%20combination%20therapy%20of%20breast%20cancer&journal=Crit.%20Rev.%20Oncog.&doi=10.1615%2FCritRevOncog.v18.i1-2.70&volume=18&pages=115-133&publication_year=2013&author=Reisfeld%2CRA's earnings
- How much cash flow does https://doi.org/10.1038%2Fnm.3337 have monthly?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24056773
- Explore the financials of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840724
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=CSF-1R%20inhibition%20alters%20macrophage%20polarization%20and%20blocks%20glioma%20progression&journal=Nat.%20Med.&doi=10.1038%2Fnm.3337&volume=19&pages=1264-1272&publication_year=2013&author=Pyonteck%2CSM?
- Earnings of https://doi.org/10.1111%2Fcas.12202
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23691974 gross monthly?
- What's the income generated by http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766435 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Selective%20ablation%20of%20tumor-associated%20macrophages%20suppresses%20metastasis%20and%20angiogenesis&journal=Cancer%20Sci.&doi=10.1111%2Fcas.12202&volume=104&pages=1217-1225&publication_year=2013&author=Lin%2CY generate?
- What's https://doi.org/10.1172%2FJCI27648's gross income?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16862213 make?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513049 have monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Targeting%20tumor-associated%20macrophages%20as%20a%20novel%20strategy%20against%20breast%20cancer&journal=J.%20Clin.%20Invest.&doi=10.1172%2FJCI27648&volume=116&pages=2132-2141&publication_year=2006&author=Luo%2CY
- What's the income generated by https://link.springer.com/doi/10.1007/s00262-007-0389-x each month?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17786443 have monthly?
- How much income is http://scholar.google.com/scholar_lookup?&title=A%20legumain-based%20minigene%20vaccine%20targets%20the%20tumor%20stroma%20and%20suppresses%20breast%20cancer%20growth%20and%20angiogenesis&journal=Cancer%20Immunol.%20Immunother.&doi=10.1007%2Fs00262-007-0389-x&volume=57&pages=507-515&publication_year=2008&author=Lewen%2CS earning monthly?
- Profit of https://doi.org/10.1111%2Fj.1600-065X.2008.00613.x
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18363997?
- Get to know http://scholar.google.com/scholar_lookup?&title=Oral%20DNA%20vaccines%20target%20the%20tumor%20vasculature%20and%20microenvironment%20and%20suppress%20tumor%20growth%20and%20metastasis&journal=Immunol.%20Rev.&doi=10.1111%2Fj.1600-065X.2008.00613.x&volume=222&pages=117-128&publication_year=2008&author=Xiang%2CR&author=Luo%2CY&author=Niethammer%2CAG&author=Reisfeld%2CRA's earnings
- How much does https://doi.org/10.1073%2Fpnas.1300686110 bring in each month?
- Profit of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2013PNAS..11010940D
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23776206 income
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703970?
- What's http://scholar.google.com/scholar_lookup?&title=Mechanistic%20and%20structural%20studies%20on%20legumain%20explain%20its%20zymogenicity%2C%20distinct%20activation%20pathways%2C%20and%20regulation&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.1300686110&volume=110&pages=10940-10945&publication_year=2013&author=Dall%2CE&author=Brandstetter%2CH's gross income?
- What's the total monthly financial gain of https://doi.org/10.1096%2Ffj.10-172312?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21292981's financial summary
- How much profit does http://scholar.google.com/scholar_lookup?&title=Asparagine%20endopeptidase%20is%20required%20for%20normal%20kidney%20physiology%20and%20homeostasis&journal=FASEB%20J.&doi=10.1096%2Ffj.10-172312&volume=25&pages=1606-1617&publication_year=2011&author=Miller%2CG&author=Matthews%2CSP&author=Reinheckel%2CT&author=Fleming%2CS&author=Watts%2CC make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12782603 make?
- How much income does http://scholar.google.com/scholar_lookup?&title=Overexpression%20of%20legumain%20in%20tumors%20is%20significant%20for%20invasion%2Fmetastasis%20and%20a%20candidate%20enzymatic%20target%20for%20prodrug%20therapy&journal=Cancer%20Res.&volume=63&pages=2957-2964&publication_year=2003&author=Liu%2CC&author=Sun%2CC&author=Huang%2CH&author=Janda%2CK&author=Edgington%2CT have?
- How much does https://doi.org/10.1016%2Fj.biomaterials.2013.09.100 pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24120038 gross monthly?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Peptide-based%20MRI%20contrast%20agent%20and%20near-infrared%20fluorescent%20probe%20for%20intratumoral%20legumain%20detection&journal=Biomaterials&doi=10.1016%2Fj.biomaterials.2013.09.100&volume=35&pages=304-315&publication_year=2013&author=Chen%2CYJ have monthly?
- Discover the revenue of https://link.springer.com/doi/10.1007/s12032-013-0621-9
- Get to know http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2013tdsc.book.....L's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23740003 bring in each month?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20legumain%20as%20a%20potential%20prognostic%20factor%20on%20gastric%20cancers&journal=Med.%20Oncol.&doi=10.1007%2Fs12032-013-0621-9&volume=30&publication_year=2013&author=Li%2CN
- Earnings of https://doi.org/10.1016%2Fj.nano.2011.03.001
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21419870's earnings
- http://scholar.google.com/scholar_lookup?&title=Synthetic%20enzyme%20inhibitor%3A%20a%20novel%20targeting%20ligand%20for%20nanotherapeutic%20drug%20delivery%20inhibiting%20tumor%20growth%20without%20systemic%20toxicity&journal=Nanomedicine&doi=10.1016%2Fj.nano.2011.03.001&volume=7&pages=665-673&publication_year=2011&author=Liao%2CD's total income per month
- How much does https://doi.org/10.1021%2Fja307083b gross monthly?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23215039
- How much income does http://scholar.google.com/scholar_lookup?&title=Functional%20imaging%20of%20legumain%20in%20cancer%20using%20a%20new%20quenched%20activity-based%20probe&journal=J.%20Am.%20Chem.%20Soc.&doi=10.1021%2Fja307083b&volume=135&pages=174-182&publication_year=2013&author=Edgington%2CLE have?
- What's the financial intake of https://doi.org/10.1021%2Fmp200434n?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22044266's revenue stream
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Targeting%20cell%20surface%20alpha%28v%29beta%283%29%20integrin%20increases%20therapeutic%20efficacies%20of%20a%20legumain%20protease-activated%20auristatin%20prodrug&journal=Mol.%20Pharm.&doi=10.1021%2Fmp200434n&volume=9&pages=168-175&publication_year=2012&author=Liu%2CY&author=Bajjuri%2CKM&author=Liu%2CC&author=Sinha%2CSC produce monthly?
- What's the monthly income of https://doi.org/10.1002%2Fcmdc.201000478?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21154805
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549592 making per month?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=The%20legumain%20protease-activated%20auristatin%20prodrugs%20suppress%20tumor%20growth%20and%20metastasis%20without%20toxicity&journal=ChemMedChem&doi=10.1002%2Fcmdc.201000478&volume=6&pages=54-59&publication_year=2011&author=Bajjuri%2CKM&author=Liu%2CY&author=Liu%2CC&author=Sinha%2CSC
- How much does https://doi.org/10.1158%2F0008-5472.CAN-05-2591 earn?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16424032 earns monthly
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Targeting%20cell-impermeable%20prodrug%20activation%20to%20tumor%20microenvironment%20eradicates%20multiple%20drug-resistant%20neoplasms&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-05-2591&volume=66&pages=970-980&publication_year=2006&author=Wu%2CW
- What is the monthly revenue of https://doi.org/10.1021%2Fbc800448u?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19196156 produce monthly?
- http://scholar.google.com/scholar_lookup?&title=A%20novel%20antitumor%20prodrug%20platform%20designed%20to%20be%20cleaved%20by%20the%20endoprotease%20legumain&journal=Bioconjug.%20Chem.&doi=10.1021%2Fbc800448u&volume=20&pages=500-510&publication_year=2009&author=Stern%2CL's revenue stream
- https://doi.org/10.2217%2Fnnm.13.118 income
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Current%20trends%20in%20the%20use%20of%20liposomes%20for%20tumor%20targeting&journal=Nanomedicine%20%28Lond%29&doi=10.2217%2Fnnm.13.118&volume=8&pages=1323-1342&publication_year=2013&author=Deshpande%2CPP&author=Biswas%2CS&author=Torchilin%2CVP
- How much profit is https://link.springer.com/doi/10.1007/978-1-61779-151-2_23 making per month?
- What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21674343?
- Profit of http://scholar.google.com/scholar_lookup?&title=Design%20and%20synthesis%20of%20novel%20functional%20lipid-based%20bioconjugates%20for%20drug%20delivery%20and%20other%20applications&journal=Methods%20Mol.%20Biol.&doi=10.1007%2F978-1-61779-151-2_23&volume=751&pages=357-378&publication_year=2011&author=Sawant%2CRR&author=Torchilin%2CVP
- https://doi.org/10.1002%2Fbip.20989's financial summary
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18381624 pull in monthly?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Cell%20penetrating%20peptide-modified%20pharmaceutical%20nanocarriers%20for%20intracellular%20drug%20and%20gene%20delivery&journal=Biopolymers&doi=10.1002%2Fbip.20989&volume=90&pages=604-610&publication_year=2008&author=Torchilin%2CVP?
- How much money does https://doi.org/10.1016%2Fj.jconrel.2004.10.018 generate?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15653149 generate?
- See how much http://scholar.google.com/scholar_lookup?&title=Cationic%20TAT%20peptide%20transduction%20domain%20enters%20cells%20by%20macropinocytosis&journal=J.%20Control.%20Release&doi=10.1016%2Fj.jconrel.2004.10.018&volume=102&pages=247-253&publication_year=2005&author=Kaplan%2CIM&author=Wadia%2CJS&author=Dowdy%2CSF makes per month
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=SOX2%20regulates%20apoptosis%20through%20MAP4K4-Survivin%20signaling%20pathway%20in%20human%20lung%20cancer%20cells&journal=Carcinogenesis&volume=14&publication_year=2013&author=Chen%2CS?
- How much revenue does https://doi.org/10.1371%2Fjournal.pone.0060190 bring in?
- What's the profit of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2013PLoSO...860190L?
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23577091?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618226
- Earnings of http://scholar.google.com/scholar_lookup?&title=Alginic%20acid-coated%20chitosan%20nanoparticles%20loaded%20with%20legumain%20DNA%20vaccine%3A%20effect%20against%20breast%20cancer%20in%20mice&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0060190&volume=8&publication_year=2013&author=Liu%2CZ
- What are the total earnings of https://doi.org/10.1515%2FBC.2002.133?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12437107 income
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20mammalian%20legumain%20by%20Michael%20acceptors%20and%20AzaAsn-halomethylketones&journal=Biol.%20Chem.&doi=10.1515%2FBC.2002.133&volume=383&pages=1205-1214&publication_year=2002&author=Niestroj%2CAJ bring in each month?
- What's the monthly income of https://doi.org/10.1021%2Fjm049938j?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15055989 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Aza-peptide%20Michael%20acceptors%3A%20a%20new%20class%20of%20inhibitors%20specific%20for%20caspases%20and%20other%20clan%20CD%20cysteine%20proteases&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm049938j&volume=47&pages=1889-1892&publication_year=2004&author=Ekici%2COD net monthly?
- What's the financial gain of https://doi.org/10.1073%2Fpnas.0803728105?
- How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2008PNAS..105.9343M gross monthly?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18607000
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453735 bring in each month?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Nanoparticle-mediated%20drug%20delivery%20to%20tumor%20vasculature%20suppresses%20metastasis&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0803728105&volume=105&pages=9343-9348&publication_year=2008&author=Murphy%2CEA?
- Learn about the earnings of https://doi.org/10.1021%2Fjm701311r
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18416543 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Aza-peptidyl%20Michael%20acceptors.%20A%20new%20class%20of%20potent%20and%20selective%20inhibitors%20of%20asparaginyl%20endopeptidases%20%28legumains%29%20from%20evolutionarily%20diverse%20pathogens&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm701311r&volume=51&pages=2816-2832&publication_year=2008&author=Gotz%2CMG make?
- Discover the revenue of https://doi.org/10.1021%2Fjm0601405
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16970398 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Design%2C%20synthesis%2C%20and%20evaluation%20of%20aza-peptide%20Michael%20acceptors%20as%20selective%20and%20potent%20inhibitors%20of%20caspases-2%2C%20-3%2C%20-6%2C%20-7%2C%20-8%2C%20-9%2C%20and%20-10&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm0601405&volume=49&pages=5728-5749&publication_year=2006&author=Ekici%2COD pull in monthly?
- What's the income of https://doi.org/10.1021%2Fjm900849h?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19848405 generate monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Aza-peptidyl%20Michael%20acceptor%20and%20epoxide%20inhibitors%E2%80%94potent%20and%20selective%20inhibitors%20of%20Schistosoma%20mansoni%20and%20Ixodes%20ricinus%20legumains%20%28asparaginyl%20endopeptidases%29&journal=J.%20Med.%20Chem.&doi=10.1021%2Fjm900849h&volume=52&pages=7192-7210&publication_year=2009&author=Ovat%2CA make?
- Financial intake of https://citation-needed.springer.com/v2/references/10.1038/ncomms5280?format=refman&flavour=references
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ze%20Liu generate?
- What's the financial intake of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ze%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Min%20Xiong pull in?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Min%20Xiong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Junbo%20Gong
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Junbo%20Gong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yan%20Zhang pull in monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yan%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Nan%20Bai?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Nan%20Bai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yunping%20Luo
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yunping%20Luo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luyuan%20Li generate?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luyuan%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuquan%20Wei?
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuquan%20Wei%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yanhua%20Liu generate monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yanhua%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiaoyue%20Tan
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiaoyue%20Tan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rong%20Xiang pull in?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rong%20Xiang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- Monthly income for https://static-content.springer.com/esm/art%3A10.1038%2Fncomms5280/MediaObjects/41467_2014_BFncomms5280_MOESM1158_ESM.pdf
- How much money does https://s100.copyright.com/AppDispatchServlet?title=Legumain%20protease-activated%20TAT-liposome%20cargo%20for%20targeting%20tumours%20and%20their%20microenvironment&author=Ze%20Liu%20et%20al&contentID=10.1038%2Fncomms5280©right=Springer%20Nature%20Limited&publication=2041-1723&publicationDate=2014-06-27&publisherName=SpringerNature&orderBeanReset=true generate?
- How much does https://crossmark.crossref.org/dialog/?doi=10.1038/ncomms5280 rake in every month?
- How much does https://citation-needed.springer.com/v2/references/10.1038/ncomms5280?format=refman&flavour=citation rake in every month?
- What's the total monthly financial gain of https://doi.org/10.1007/s12274-022-5076-x?
- How much does https://doi.org/10.1007/s12274-021-3976-9 generate monthly?
- https://doi.org/10.1007/s10637-020-01011-3's revenue stream
- Monthly income for https://doi.org/10.1007/s12274-020-2996-1
- How much does https://doi.org/10.1007/s00280-019-03906-2 make?
- How much revenue does https://www.protocols.io/ bring in?
- How much does https://www.natureindex.com/ generate monthly?
- What's the total monthly financial gain of http://www.naturechina.com?
- What's the financial outcome of https://www.natureasia.com/ja-jp?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Particles.js
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref